Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
10.08
-0.13 (-1.32%)
May 1, 2026, 10:28 AM EDT - Market open
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.63 billion as of May 1, 2026. Its market cap has increased by 110.87% in one year.
Market Cap
1.63B
Enterprise Value
1.25B
1-Year Change
110.87%
Ranking
Category
Stock Price
$10.08
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has increased from $1.53B to $1.63B, an increase of 5.97%. That is a compound annual growth rate of 0.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 30, 2026 | 1.65B | 96.32% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recursion Pharmaceuticals | 1.74B |
| Nurix Therapeutics | 1.72B |
| Innoviva | 1.71B |
| Vericel | 1.70B |
| Sionna Therapeutics | 1.69B |
| Agios Pharmaceuticals | 1.64B |
| Nanobiotix | 1.60B |
| Generate Biomedicines | 1.58B |